Identification, evaluation, and management of children with autism spectrum disorder

SL Hyman, SE Levy, SM Myers, DZ Kuo, S Apkon… - …, 2020 - publications.aap.org
Autism spectrum disorder (ASD) is a common neurodevelopmental disorder with reported
prevalence in the United States of 1 in 59 children (approximately 1.7%). Core deficits are …

Genetic testing in neurodevelopmental disorders

JM Savatt, SM Myers - Frontiers in Pediatrics, 2021 - frontiersin.org
Neurodevelopmental disorders are the most prevalent chronic medical conditions
encountered in pediatric primary care. In addition to identifying appropriate descriptive …

Molecular findings among patients referred for clinical whole-exome sequencing

Y Yang, DM Muzny, F **a, Z Niu, R Person, Y Ding… - Jama, 2014 - jamanetwork.com
Importance Clinical whole-exome sequencing is increasingly used for diagnostic evaluation
of patients with suspected genetic disorders. Objective To perform clinical whole-exome …

Clinical whole-exome sequencing for the diagnosis of mendelian disorders

Y Yang, DM Muzny, JG Reid… - … England Journal of …, 2013 - Mass Medical Soc
Background Whole-exome sequencing is a diagnostic approach for the identification of
molecular defects in patients with suspected genetic disorders. Methods We developed …

[HTML][HTML] A clinical primer on intellectual disability

DR Patel, MD Cabral, A Ho, J Merrick - Translational pediatrics, 2020 - ncbi.nlm.nih.gov
Abstract Between 1% and 3% of persons in general population are estimated to have some
degree of intellectual disability. A diagnosis of intellectual disability is based on clinical …

Comprehensive evaluation of the child with intellectual disability or global developmental delays

JB Moeschler, M Shevell, Committee on Genetics… - …, 2014 - publications.aap.org
Global developmental delay and intellectual disability are relatively common pediatric
conditions. This report describes the recommended clinical genetics diagnostic approach …

Clinical exome sequencing: results from 2819 samples reflecting 1000 families

D Trujillano, AM Bertoli-Avella… - European Journal of …, 2017 - nature.com
We report our results of 1000 diagnostic WES cases based on 2819 sequenced samples
from 54 countries with a wide phenotypic spectrum. Clinical information given by the …

[HTML][HTML] Developmental delay: identification and management at primary care level

YY Choo, P Agarwal, CH How… - Singapore medical …, 2019 - ncbi.nlm.nih.gov
Developmental delays are common in childhood, occurring in 10%–15% of preschool
children. Global developmental delays are less common, occurring in 1%–3% of preschool …

Whole-genome sequencing expands diagnostic utility and improves clinical management in paediatric medicine

DJ Stavropoulos, D Merico, R Jobling, S Bowdin… - NPJ genomic …, 2016 - nature.com
The standard of care for first-tier clinical investigation of the aetiology of congenital
malformations and neurodevelopmental disorders is chromosome microarray analysis …

Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies

DT Miller, MP Adam, S Aradhya, LG Biesecker… - The American Journal of …, 2010 - cell.com
Chromosomal microarray (CMA) is increasingly utilized for genetic testing of individuals with
unexplained developmental delay/intellectual disability (DD/ID), autism spectrum disorders …